The pro‐or anti‐apoptotic function of NF‐κB is determined by the nature of the apoptotic stimulus

B Kaltschmidt, C Kaltschmidt… - European journal of …, 2000 - Wiley Online Library
B Kaltschmidt, C Kaltschmidt, TG Hofmann, SP Hehner, W Dröge, ML Schmitz
European journal of biochemistry, 2000Wiley Online Library
To test whether the behaviour of transcription factor NF‐κB as a promoter or antagonist of
apoptosis depends on the apoptotic stimulus, we determined the influence of NF‐κB on cell
killing elicited by a variety of inducers within a given cell type. Inhibition of NF‐κB by genetic
and pharmacological approaches rendered HeLa cells more susceptible to TNF‐α‐induced
cell killing, but protected them almost completely from H2O2‐and pervanadate‐induced
apoptosis. TNF‐α was unable to protect HeLa from H2O2‐and pervanadate‐induced …
To test whether the behaviour of transcription factor NF‐κB as a promoter or antagonist of apoptosis depends on the apoptotic stimulus, we determined the influence of NF‐κB on cell killing elicited by a variety of inducers within a given cell type. Inhibition of NF‐κB by genetic and pharmacological approaches rendered HeLa cells more susceptible to TNF‐α‐induced cell killing, but protected them almost completely from H2O2‐ and pervanadate‐induced apoptosis. TNF‐α was unable to protect HeLa from H2O2‐ and pervanadate‐induced apoptosis and further enhanced the cytotoxicity induced by these two adverse agents. Supernatants from HeLa cells stably overexpressing a transdominant negative form of IκB‐α selectively increased the cytotoxicity of TNF‐α for HeLa cells, suggesting that the enhanced susceptibility of these cells can be attributed to one or more secretable factors. Supershift experiments showed that the various apoptotic stimuli induced the same subset of DNA‐binding subunits. Therefore, the nature of the signals elicited by the respective death inducers determines whether NF‐κB induction leads to apoptosis or survival, suggesting that the manipulation of NF‐κB activity may provide a new approach to adjuvant therapy in cancer treatment.
Wiley Online Library